@article{alcazarConcentrationDependencyTimeProfile2019,
  title = {Concentration-{{Dependency}} and {{Time Profile}} of {{Insulin Secretion}}: {{Dynamic Perifusion Studies With Human}} and {{Murine Islets}}},
  shorttitle = {Concentration-{{Dependency}} and {{Time Profile}} of {{Insulin Secretion}}},
  author = {Alcazar, Oscar and Buchwald, Peter},
  year = {2019},
  month = oct,
  journal = {Frontiers in Endocrinology},
  volume = {10},
  pages = {680},
  issn = {1664-2392},
  doi = {10.3389/fendo.2019.00680},
  urldate = {2024-04-30},
  abstract = {The detailed characterization and quantification of the kinetics of glucose-stimulated insulin secretion (GSIS) by normal pancreatic islets is of considerable interest for characterizing {$\beta$}-cell dysfunction, assessing the quality of isolated islets, and improving the design of artificial pancreas devices. Here, we performed dynamic evaluation of GSIS by human and mouse islets at high temporal resolution (every minute) in response to different glucose steps using an automated multichannel perifusion instrument. In both species, insulin responses were biphasic (a transient first-phase peak followed by a sustained second-phase), and the amount of insulin released showed a sigmoid-type dependence on glucose concentration. However, compared to murine islets, human islets have (1) a less pronounced first-phase response, (2) a flat secretion rate during second-phase response, (3) a left-shifted concentration response (reaching half-maximal response at 7.9 {\textpm} 0.4 vs. 13.7 {\textpm} 0.6 mM), and (4) an {$\sim$}3-fold lower maximal secretion rate (8.3 {\textpm} 2.3 vs. 23.9 {\textpm} 5.1 pg/min/islet at 30 mM glucose). These results can be used to establish a more informative protocol for the calculation of the stimulation index, which is widely used for islet assessment in both research and clinical applications, but without an accepted standard or clear evidence as to what low- to high-glucose steps can provide better characterization of islet function. Data obtained here suggest that human islet functionality might be best characterized with a dynamic stimulation index obtained with a glucose step from a low of 4--5 to a high of 14--17 mM (e.g., G4 {$\rightarrow$} G16).},
  langid = {english},
  file = {/Users/wudw/Zotero/storage/GIB4JATA/Alcazar and Buchwald - 2019 - Concentration-Dependency and Time Profile of Insul.pdf}
}

@book{alonSystemsMedicinePhysiological2023,
  title = {Systems {{Medicine}}: {{Physiological Circuits}} and the {{Dynamics}} of {{Disease}}},
  shorttitle = {Systems {{Medicine}}},
  author = {Alon, Uri},
  year = {2023},
  month = dec,
  publisher = {{Chapman and Hall/CRC}},
  address = {New York},
  doi = {10.1201/9781003356929},
  abstract = {Why do we get certain diseases, whereas other diseases do not exist? In this book, Alon, one of the founders of systems biology, builds a foundation for systems medicine. Starting from basic laws, the book derives why physiological circuits are built the way they are. The circuits have fragilities that explain specific diseases and offer new strategies to treat them. By the end, the reader will be able to use simple and powerful mathematical models to describe physiological circuits. The book explores, in three parts, hormone circuits, immune circuits, and aging and age-related disease. It culminates in a periodic table of diseases. Alon writes in a style accessible to a broad range of readers - undergraduates, graduates, or researchers from computational or biological backgrounds. The level of math is friendly and the math can even be bypassed altogether. For instructors and readers who want to go deeper, the book includes dozens of exercises that have been rigorously tested in the classroom},
  isbn = {978-1-00-335692-9}
}

@article{berbudiTypeDiabetesIts2020,
  title = {Type 2 {{Diabetes}} and Its {{Impact}} on the {{Immune System}}},
  author = {Berbudi, Afiat and Rahmadika, Nofri and Tjahjadi, Adi Imam and Ruslami, Rovina},
  year = {2020},
  journal = {Current Diabetes Reviews},
  volume = {16},
  number = {5},
  pages = {442--449},
  issn = {1875-6417},
  doi = {10.2174/1573399815666191024085838},
  abstract = {INTRODUCTION: Type 2 Diabetes (T2D) is a major health problem worldwide. This metabolic disease is indicated by high blood glucose levels due to insufficient insulin production by the pancreas. An inflammatory response occurs as a result of the immune response to high blood glucose levels as well as the presence of inflammatory mediators produced by adipocytes and macrophages in fat tissue. This low and chronic inflammation damages the pancreatic beta cells and leads to insufficient insulin production, which results in hyperglycemia. Hyperglycemia in diabetes is thought to cause dysfunction of the immune response, which fails to control the spread of invading pathogens in diabetic subjects. Therefore, diabetic subjects are known to more susceptible to infections. The increased prevalence of T2D will increase the incidence of infectious diseases and related comorbidities. OBJECTIVE: This review provides an overview of the immunological aspect of T2D and the possible mechanisms that result in increased infections in diabetics. CONCLUSION: A better understanding of how immune dysfunctions occur during hyperglycemia can lead to novel treatments and preventions for infectious diseases and T2D comorbidities, thus improving the outcome of infectious disease treatment in T2D patients.},
  langid = {english},
  pmcid = {PMC7475801},
  pmid = {31657690},
  keywords = {Chronic Disease,comorbidity,Diabetes Mellitus Type 2,Humans,hyperglycemia,Hyperglycemia,immune dysfunction,Immune System,infection,Infections,Inflammation,Insulin,Insulin-Secreting Cells,treatment outcome.,Type 2 diabetes},
  file = {/Users/wudw/Zotero/storage/GVXX6C4Q/Berbudi et al. - 2020 - Type 2 Diabetes and its Impact on the Immune System.pdf}
}

@article{bhagchandaniTwodoseExtendedPriming2023,
  title = {Two-Dose "Extended Priming" Immunization Amplifies Humoral Immune Responses by Synchronizing Vaccine Delivery with the Germinal Center Response},
  author = {Bhagchandani, Sachin H. and Yang, Leerang and Maiorino, Laura and {Ben-Akiva}, Elana and Rodrigues, Kristen A. and Romanov, Anna and Suh, Heikyung and Aung, Aereas and Wu, Shengwei and Wadhera, Anika and Chakraborty, Arup K. and Irvine, Darrell J.},
  year = {2023},
  month = nov,
  journal = {bioRxiv: The Preprint Server for Biology},
  pages = {2023.11.20.563479},
  doi = {10.1101/2023.11.20.563479},
  abstract = {"Extended priming" immunization regimens that prolong exposure of the immune system to vaccines during the primary immune response have shown promise in enhancing humoral immune responses to a variety of subunit vaccines in preclinical models. We previously showed that escalating-dosing immunization (EDI), where a vaccine is dosed every other day in an increasing pattern over 2 weeks dramatically amplifies humoral immune responses. But such a dosing regimen is impractical for prophylactic vaccines. We hypothesized that simpler dosing regimens might replicate key elements of the immune response triggered by EDI. Here we explored "reduced ED" immunization regimens, assessing the impact of varying the number of injections, dose levels, and dosing intervals during EDI. Using a stabilized HIV Env trimer as a model antigen combined with a potent saponin adjuvant, we found that a two-shot extended-prime regimen consisting of immunization with 20\% of a given vaccine dose followed by a second shot with the remaining 80\% of the dose 7 days later resulted in increased total GC B cells, 5-10-fold increased frequencies of antigen-specific GC B cells, and 10-fold increases in serum antibody titers compared to single bolus immunization. Computational modeling of the GC response suggested that this enhanced response is mediated by antigen delivered in the second dose being captured more efficiently as immune complexes in follicles, predictions we verified experimentally. Our computational and experimental results also highlight how properly designed reduced ED protocols enhance activation and antigen loading of dendritic cells and activation of T helper cells to amplify humoral responses. These results suggest that a two-shot priming approach can be used to substantially enhance responses to subunit vaccines.},
  langid = {english},
  pmcid = {PMC10690148},
  pmid = {38045401},
  file = {/Users/wudw/Zotero/storage/QRGUW6MR/Bhagchandani et al. - 2023 - Two-dose extended priming immunization amplifies.pdf}
}

@article{birdGettingEnoughEnergy2019,
  title = {Getting Enough Energy for Immunity},
  author = {Bird, Lucy},
  year = {2019},
  month = may,
  journal = {Nature Reviews Immunology},
  volume = {19},
  number = {5},
  pages = {269--269},
  issn = {1474-1733, 1474-1741},
  doi = {10.1038/s41577-019-0159-y},
  urldate = {2024-04-29},
  langid = {english},
  file = {/Users/wudw/Zotero/storage/US4FV74G/Bird - 2019 - Getting enough energy for immunity.pdf}
}

@article{caoMetabolicReprogrammingAerobic2014,
  title = {Metabolic {{Reprogramming}} towards {{Aerobic Glycolysis Correlates}} with {{Greater Proliferative Ability}} and {{Resistance}} to {{Metabolic Inhibition}} in {{CD8}} versus {{CD4 T Cells}}},
  author = {Cao, Yilin and Rathmell, Jeffrey C. and Macintyre, Andrew N.},
  editor = {Platten, Michael},
  year = {2014},
  month = aug,
  journal = {PLoS ONE},
  volume = {9},
  number = {8},
  pages = {e104104},
  issn = {1932-6203},
  doi = {10.1371/journal.pone.0104104},
  urldate = {2024-04-30},
  abstract = {T lymphocytes (T cells) undergo metabolic reprogramming after activation to provide energy and biosynthetic materials for growth, proliferation and differentiation. Distinct T cell subsets, however, adopt metabolic programs specific to support their needs. As CD4 T cells coordinate adaptive immune responses while CD8 T cells become cytotoxic effectors, we compared activation-induced proliferation and metabolic reprogramming of these subsets. Resting CD4 and CD8 T cells were metabolically similar and used a predominantly oxidative metabolism. Following activation CD8 T cells proliferated more rapidly. Stimulation led both CD4 and CD8 T cells to sharply increase glucose metabolism and adopt aerobic glycolysis as a primary metabolic program. Activated CD4 T cells, however, remained more oxidative and had greater maximal respiratory capacity than activated CD8 T cells. CD4 T cells were also associated with greater levels of ROS and increased mitochondrial content, irrespective of the activation context. CD8 cells were better able, however, to oxidize glutamine as an alternative fuel source. The more glycolytic metabolism of activated CD8 T cells correlated with increased capacity for growth and proliferation, along with reduced sensitivity of cell growth to metabolic inhibition. These specific metabolic programs may promote greater growth and proliferation of CD8 T cells and enhance survival in diverse nutrient conditions.},
  langid = {english},
  file = {/Users/wudw/Zotero/storage/JAHI2CMA/Cao et al. - 2014 - Metabolic Reprogramming towards Aerobic Glycolysis.pdf}
}

@article{carpenterPeripheryCenterStage2024,
  title = {From Periphery to Center Stage: 50 Years of Advancements in Innate Immunity},
  shorttitle = {From Periphery to Center Stage},
  author = {Carpenter, Susan and O'Neill, Luke A.J.},
  year = {2024},
  month = apr,
  journal = {Cell},
  volume = {187},
  number = {9},
  pages = {2030--2051},
  issn = {00928674},
  doi = {10.1016/j.cell.2024.03.036},
  urldate = {2024-04-28},
  abstract = {Over the past 50 years in the field of immunology, something of a Copernican revolution has happened. For a long time, immunologists were mainly concerned with what is termed adaptive immunity, which involves the exquisitely specific activities of lymphocytes. But the other arm of immunity, so-called ``innate immunity,'' had been neglected. To celebrate Cell's 50th anniversary, we have put together a review of the processes and components of innate immunity and trace the seminal contributions leading to the modern state of this field. Innate immunity has joined adaptive immunity in the center of interest for all those who study the body's defenses, as well as homeostasis and pathology. We are now entering the era where therapeutic targeting of innate immune receptors and downstream signals hold substantial promise for infectious and inflammatory diseases and cancer.},
  langid = {english},
  file = {/Users/wudw/Zotero/storage/S98UMUFV/Carpenter and Oâ€™Neill - 2024 - From periphery to center stage 50 years of advanc.pdf}
}

@article{chapmanMetabolicAdaptationLymphocytes2022,
  title = {Metabolic Adaptation of Lymphocytes in Immunity and Disease},
  author = {Chapman, Nicole M. and Chi, Hongbo},
  year = {2022},
  month = jan,
  journal = {Immunity},
  volume = {55},
  number = {1},
  pages = {14--30},
  issn = {10747613},
  doi = {10.1016/j.immuni.2021.12.012},
  urldate = {2024-04-29},
  abstract = {Adaptive immune responses mediated by T cells and B cells are crucial for protective immunity against pathogens and tumors. Differentiation and function of immune cells require dynamic reprogramming of cellular metabolism. Metabolic inputs, pathways, and enzymes display remarkable flexibility and heterogeneity, especially in vivo. How metabolic plasticity and adaptation dictate functional specialization of immune cells is fundamental to our understanding and therapeutic modulation of the immune system. Immense progress has been made in characterizing the effects of metabolic networks on immune cell fate and function in discrete microenvironments or immunological contexts. In this review, we summarize how rewiring of cellular metabolism determines the outcome of adaptive immunity in vivo, with a focus on how metabolites, nutrients, and driver genes in immunometabolism instruct cellular programming and immune responses during infection, inflammation, and cancer in mice and humans. Understanding context-dependent metabolic remodeling will manifest legitimate opportunities for therapeutic intervention of human disease.},
  langid = {english},
  file = {/Users/wudw/Zotero/storage/9PUVWQ6N/Chapman and Chi - 2022 - Metabolic adaptation of lymphocytes in immunity an.pdf}
}

@article{chenViciousCircleInsulin2017,
  title = {A Vicious Circle between Insulin Resistance and Inflammation in Nonalcoholic Fatty Liver Disease},
  author = {Chen, Zhonge and Yu, Rong and Xiong, Ying and Du, Fangteng and Zhu, Shuishan},
  year = {2017},
  month = oct,
  journal = {Lipids in Health and Disease},
  volume = {16},
  number = {1},
  pages = {203},
  issn = {1476-511X},
  doi = {10.1186/s12944-017-0572-9},
  urldate = {2024-05-13},
  abstract = {Nonalcoholic fatty liver disease (NAFLD) comprises a spectrum of diseases, including simple steatosis, nonalcoholic steatohepatitis (NASH), liver cirrhosis and hepatocellular carcinoma. Lipotoxicity, insulin resistance (IR) and inflammation are involved in the disease process. Lipotoxicity promotes inflammation and IR, which in turn, increase adipocyte lipolysis and exacerbates lipotoxicity. Furthermore, IR and inflammation form a vicious circle, with each condition promoting the other and accelerating the development of NAFLD in the presence of lipotoxicity. As an integrator of inflammatory pathway networks, nuclear factor-kappa B (NF-{$\kappa$}B) regulates expression of pro-inflammatory cytokines, such as tumor necrosis factor-alpha (TNF-{$\alpha$}), interleukin 6 (IL-6), and anti-inflammatory cytokines, such as adiponectin in NAFLD. In this review, the relationships between lipotoxicity, IR and inflammation in NAFLD are discussed, with particular emphasis on the inflammatory pathways.},
  keywords = {Lipotoxicity,NAFLD Patients,Nonalcoholic Fatty Liver Disease (NAFLD),Nonalcoholic Steatohepatitis (NASH),Simple Steatosis},
  file = {/Users/wudw/Zotero/storage/VLLIJ7EF/Chen et al. - 2017 - A vicious circle between insulin resistance and inflammation in nonalcoholic fatty liver disease.pdf}
}

@article{chiPrinciplesTherapeuticApplications2024,
  title = {Principles and Therapeutic Applications of Adaptive Immunity},
  author = {Chi, Hongbo and Pepper, Marion and Thomas, Paul G.},
  year = {2024},
  month = apr,
  journal = {Cell},
  volume = {187},
  number = {9},
  pages = {2052--2078},
  issn = {00928674},
  doi = {10.1016/j.cell.2024.03.037},
  urldate = {2024-04-28},
  abstract = {Adaptive immunity provides protection against infectious and malignant diseases. These effects are mediated by lymphocytes that sense and respond with targeted precision to perturbations induced by pathogens and tissue damage. Here, we review key principles underlying adaptive immunity orchestrated by distinct T cell and B cell populations and their extensions to disease therapies. We discuss the intracellular and intercellular processes shaping antigen specificity and recognition in immune activation and lymphocyte functions in mediating effector and memory responses. We also describe how lymphocytes balance protective immunity against autoimmunity and immunopathology, including during immune tolerance, response to chronic antigen stimulation, and adaptation to non-lymphoid tissues in coordinating tissue immunity and homeostasis. Finally, we discuss extracellular signals and cell-intrinsic programs underpinning adaptive immunity and conclude by summarizing key advances in vaccination and engineering adaptive immune responses for therapeutic interventions. A deeper understanding of these principles holds promise for uncovering new means to improve human health.},
  langid = {english},
  file = {/Users/wudw/Zotero/storage/JRAMTM45/Chi et al. - 2024 - Principles and therapeutic applications of adaptiv.pdf}
}

@article{chouImpactIntracellularInnate2022,
  title = {Impact of Intracellular Innate Immune Receptors on Immunometabolism},
  author = {Chou, Wei-Chun and Rampanelli, Elena and Li, Xin and Ting, Jenny P.-Y.},
  year = {2022},
  month = mar,
  journal = {Cellular \& Molecular Immunology},
  volume = {19},
  number = {3},
  pages = {337--351},
  issn = {1672-7681, 2042-0226},
  doi = {10.1038/s41423-021-00780-y},
  urldate = {2024-04-29},
  abstract = {Abstract             Immunometabolism, which is the metabolic reprogramming of anaerobic glycolysis, oxidative phosphorylation, and metabolite synthesis upon immune cell activation, has gained importance as a regulator of the homeostasis, activation, proliferation, and differentiation of innate and adaptive immune cell subsets that function as key factors in immunity. Metabolic changes in epithelial and other stromal cells in response to different stimulatory signals are also crucial in infection, inflammation, cancer, autoimmune diseases, and metabolic disorders. The crosstalk between the PI3K--AKT--mTOR and LKB1--AMPK signaling pathways is critical for modulating both immune and nonimmune cell metabolism. The bidirectional interaction between immune cells and metabolism is a topic of intense study. Toll-like receptors (TLRs), cytokine receptors, and T and B cell receptors have been shown to activate multiple downstream metabolic pathways. However, how intracellular innate immune sensors/receptors intersect with metabolic pathways is less well understood. The goal of this review is to examine the link between immunometabolism and the functions of several intracellular innate immune sensors or receptors, such as nucleotide-binding and leucine-rich repeat-containing receptors (NLRs, or NOD-like receptors), absent in melanoma 2 (AIM2)-like receptors (ALRs), and the cyclic dinucleotide receptor stimulator of interferon genes (STING). We will focus on recent advances and describe the impact of these intracellular innate immune receptors on multiple metabolic pathways. Whenever appropriate, this review will provide a brief contextual connection to pathogenic infections, autoimmune diseases, cancers, metabolic disorders, and/or inflammatory bowel diseases.},
  langid = {english},
  file = {/Users/wudw/Zotero/storage/4IZPKMZC/Chou et al. - 2022 - Impact of intracellular innate immune receptors on.pdf}
}

@article{cohenNovelModelIts2021,
  title = {A {{Novel Model}} and Its {{Analysis}} on the {{Metabolic Regulations}} of {{Glucose}}, {{Insulin}}, and {{Glucagon}}},
  author = {Cohen, Reed B. and Li, Jiaxu},
  year = {2021},
  month = jan,
  journal = {SIAM Journal on Applied Mathematics},
  volume = {81},
  number = {6},
  pages = {2684--2703},
  publisher = {{Society for Industrial and Applied Mathematics}},
  issn = {0036-1399},
  doi = {10.1137/21M1390876},
  urldate = {2024-05-15},
  abstract = {We continue a recent attempt to better understand the glucose-insulin regulatory system via a mathematical model of delay differential equations with two discrete time delays. With explicit delays, the model is more realistic in physiology, more accurate in mathematics, and more robust in applications. We study this model analytically and perform carefully designed numerical simulations by allowing two parameters to vary. Our analytical and numerical results confirm most current existing physiological observations and reveal more insightful information. The following factors are critical for ensuring the sustained oscillatory regulation and insulin secretion: (1) the time lag for insulin secretion stimulated by glucose and the newly synthesized insulin becoming ``remote insulin'' (Theorem 4.2 (b) and Theorem 5.6); (2) the delayed effect of hepatic glucose production (Theorem 4.2 (c) and Theorem 5.6); (3) moderate insulin clearance rate (Theorem 5.6 and simulations in section 6.4); and (4) nonoverwhelming glucose infusion (simulations in section 6.2, 6.3, and 6.4).},
  file = {/Users/wudw/Zotero/storage/Q8PAFWMG/Cohen and Li - 2021 - A Novel Model and its Analysis on the Metabolic Regulations of Glucose, Insulin, and Glucagon.pdf}
}

@article{donathTypeDiabetesInflammatory2011,
  title = {Type 2 Diabetes as an Inflammatory Disease},
  author = {Donath, Marc Y. and Shoelson, Steven E.},
  year = {2011},
  month = feb,
  journal = {Nature Reviews Immunology},
  volume = {11},
  number = {2},
  pages = {98--107},
  publisher = {Nature Publishing Group},
  issn = {1474-1741},
  doi = {10.1038/nri2925},
  urldate = {2024-05-13},
  abstract = {Type 2 diabetes is associated with obesity, ageing and inactivity. It is due to a progressive failure of pancreatic islet {$\beta$}-cells to compensate for insulin resistance.The proposed mechanisms to explain impaired insulin secretion and sensitivity in type 2 diabetes include oxidative stress, endoplasmic reticulum stress, amyloid deposition in the pancreas, ectopic lipid deposition in muscle, liver and pancreas, and lipotoxicity and glucotoxicity. All these cellular stresses may induce an inflammatory response or are exacerbated by or associated with inflammation.Factors that are associated with innate immune responses are present in the circulation, insulin-sensitive tissues and pancreatic islets in type 2 diabetes, and this evidence supports the involvement of inflammation in the pathogenesis of this disease.Mechanisms thought to be responsible for the inflammatory state in type 2 diabetes include hypoxia and cell death of expanding adipose tissue, activation of the nuclear factor-{$\kappa$}B (NF-{$\kappa$}B) and JUN N-terminal kinase (JNK) pathways, activation of interleukin-1{$\beta$} (IL-1{$\beta$}), and recruitment and activation of immune cells.Clinical trials using IL-1 antagonists or salsalate to directly target pro-inflammatory factors in patients with type 2 diabetes show promising preliminary results and support the role of inflammation in this condition.Existing data suggest a potential role for inflammation in the pathogenesis of type 2 diabetes. The relative importance of this mechanism and the precise therapeutic consequences remain to be elucidated.},
  copyright = {2011 Springer Nature Limited},
  langid = {english},
  keywords = {Immunopathogenesis,Inflammation,Therapeutics,Type 2 diabetes},
  file = {/Users/wudw/Zotero/storage/QD3CTKXX/Donath and Shoelson - 2011 - Type 2 diabetes as an inflammatory disease.pdf}
}

@article{ganeshanEnergeticTradeOffsHypometabolic2019,
  title = {Energetic {{Trade-Offs}} and {{Hypometabolic States Promote Disease Tolerance}}},
  author = {Ganeshan, Kirthana and Nikkanen, Joni and Man, Kevin and Leong, Yew Ann and Sogawa, Yoshitaka and Maschek, J. Alan and Van Ry, Tyler and Chagwedera, D. Nyasha and Cox, James E. and Chawla, Ajay},
  year = {2019},
  month = apr,
  journal = {Cell},
  volume = {177},
  number = {2},
  pages = {399-413.e12},
  issn = {00928674},
  doi = {10.1016/j.cell.2019.01.050},
  urldate = {2024-04-29},
  abstract = {Host defenses against pathogens are energetically expensive, leading ecological immunologists to postulate that they might participate in energetic trade-offs with other maintenance programs. However, the metabolic costs of immunity and the nature of physiologic trade-offs it engages are largely unknown. We report here that activation of immunity causes an energetic trade-off with the homeothermy (the stable maintenance of core temperature), resulting in hypometabolism and hypothermia. This immunity-induced physiologic trade-off was independent of sickness behaviors but required hematopoietic sensing of lipopolysaccharide (LPS) via the toll-like receptor 4 (TLR4). Metabolomics and genome-wide expression profiling revealed that distinct metabolic programs supported entry and recovery from the energy-conserving hypometabolic state. During bacterial infections, hypometabolic states, which could be elicited by competition for energy between maintenance programs or energy restriction, promoted disease tolerance. Together, our findings suggest that energy-conserving hypometabolic states, such as dormancy, might have evolved as a mechanism of tissue tolerance.},
  langid = {english},
  file = {/Users/wudw/Zotero/storage/LFUMVD5A/Ganeshan et al. - 2019 - Energetic Trade-Offs and Hypometabolic States Prom.pdf}
}

@misc{GlucoseMakesTreg,
  title = {Glucose Makes {{Treg}} Lose Their Temper - {{ScienceDirect}}},
  urldate = {2024-05-13},
  howpublished = {https://www.sciencedirect.com/science/article/pii/S1535610821001598},
  file = {/Users/wudw/Zotero/storage/JP5TY2F6/S1535610821001598.html}
}

@article{holtHeartFailureFollowing2023,
  title = {Heart {{Failure Following Anti-Inflammatory Medications}} in {{Patients With Type}} 2 {{Diabetes Mellitus}}},
  author = {Holt, Anders and Strange, Jarl E. and Nouhravesh, Nina and Nielsen, Sebastian Kinnberg and Malik, Mariam Elmegaard and Schjerning, Anne-Marie and K, {\o}ber Lars and Torp, -Pedersen Christian and Gislason, Gunnar H. and McGettigan, Patricia and Schou, Morten and Lamberts, Morten},
  year = {2023},
  month = apr,
  journal = {Journal of the American College of Cardiology},
  volume = {81},
  number = {15},
  pages = {1459--1470},
  publisher = {American College of Cardiology Foundation},
  doi = {10.1016/j.jacc.2023.02.027},
  urldate = {2024-05-14},
  keywords = {heart failure,nonsteroidal anti-inflammatory drug,pharmacoepidemiology,type 2 diabetes mellitus},
  file = {/Users/wudw/Zotero/storage/BF9AZAT6/Holt et al. - 2023 - Heart Failure Following Anti-Inflammatory Medications in Patients With Type 2 Diabetes Mellitus.pdf}
}

@article{hulettGlucoseUptakeSkeletal2022,
  title = {Glucose {{Uptake}} by {{Skeletal Muscle}} within the {{Contexts}} of {{Type}} 2 {{Diabetes}} and {{Exercise}}: {{An Integrated Approach}}},
  shorttitle = {Glucose {{Uptake}} by {{Skeletal Muscle}} within the {{Contexts}} of {{Type}} 2 {{Diabetes}} and {{Exercise}}},
  author = {Hulett, Nicholas A. and Scalzo, Rebecca L. and Reusch, Jane E. B.},
  year = {2022},
  month = jan,
  journal = {Nutrients},
  volume = {14},
  number = {3},
  pages = {647},
  publisher = {Multidisciplinary Digital Publishing Institute},
  issn = {2072-6643},
  doi = {10.3390/nu14030647},
  urldate = {2024-05-15},
  abstract = {Type 2 diabetes continues to negatively impact the health of millions. The inability to respond to insulin to clear blood glucose (insulin resistance) is a key pathogenic driver of the disease. Skeletal muscle is the primary tissue for maintaining glucose homeostasis through glucose uptake via insulin-dependent and -independent mechanisms. Skeletal muscle is also responsive to exercise-meditated glucose transport, and as such, exercise is a cornerstone for glucose management in people with type 2 diabetes. Skeletal muscle glucose uptake requires a concert of events. First, the glucose-rich blood must be transported to the skeletal muscle. Next, the glucose must traverse the endothelium, extracellular matrix, and skeletal muscle membrane. Lastly, intracellular metabolic processes must be activated to maintain the diffusion gradient to facilitate glucose transport into the cell. This review aims to examine the physiology at each of these steps in healthy individuals, analyze the dysregulation affecting these pathways associated with type 2 diabetes, and describe the mechanisms by which exercise acts to increase glucose uptake.},
  copyright = {http://creativecommons.org/licenses/by/3.0/},
  langid = {english},
  keywords = {exercise,glucose transport,insulin resistance,skeletal muscle,type 2 diabetes},
  file = {/Users/wudw/Zotero/storage/S6HBNPJZ/Hulett et al. - 2022 - Glucose Uptake by Skeletal Muscle within the Contexts of Type 2 Diabetes and Exercise An Integrated.pdf}
}

@article{ImmunologyEveryone2024,
  title = {Immunology Is for Everyone},
  year = {2024},
  month = apr,
  journal = {Cell},
  volume = {187},
  number = {9},
  pages = {2029},
  issn = {00928674},
  doi = {10.1016/j.cell.2024.03.044},
  urldate = {2024-04-28},
  langid = {english},
  file = {/Users/wudw/Zotero/storage/CURGHG6F/2024 - Immunology is for everyone.pdf}
}

@article{izzoIncidenceTypeDiabetes2023,
  title = {Incidence of Type 2 Diabetes before and during the {{COVID-19}} Pandemic in {{Naples}}, {{Italy}}: A Longitudinal Cohort Study},
  shorttitle = {Incidence of Type 2 Diabetes before and during the {{COVID-19}} Pandemic in {{Naples}}, {{Italy}}},
  author = {Izzo, Raffaele and Pacella, Daniela and Trimarco, Valentina and Manzi, Maria Virginia and Lombardi, Angela and Piccinocchi, Roberto and Gallo, Paola and Esposito, Giovanni and Lembo, Maria and Piccinocchi, Gaetano and Morisco, Carmine and Santulli, Gaetano and Trimarco, Bruno},
  year = {2023},
  month = dec,
  journal = {eClinicalMedicine},
  volume = {66},
  publisher = {Elsevier},
  issn = {2589-5370},
  doi = {10.1016/j.eclinm.2023.102345},
  urldate = {2024-05-14},
  langid = {english},
  pmid = {38143804},
  keywords = {COVID-19,Diabetes mellitus,Public health,SARS-CoV-2,T2DM},
  file = {/Users/wudw/Zotero/storage/H5BKHXLT/Izzo et al. - 2023 - Incidence of type 2 diabetes before and during the COVID-19 pandemic in Naples, Italy a longitudina.pdf}
}

@article{kellyMetabolicReprogrammingMacrophages2015,
  title = {Metabolic Reprogramming in Macrophages and Dendritic Cells in Innate Immunity},
  author = {Kelly, Beth and O'Neill, Luke Aj},
  year = {2015},
  month = jul,
  journal = {Cell Research},
  volume = {25},
  number = {7},
  pages = {771--784},
  issn = {1001-0602, 1748-7838},
  doi = {10.1038/cr.2015.68},
  urldate = {2024-04-29},
  langid = {english},
  file = {/Users/wudw/Zotero/storage/43Q3HXL3/Kelly and O'Neill - 2015 - Metabolic reprogramming in macrophages and dendrit.pdf}
}

@article{kistnerInterleukinEnergyAllocator2022,
  title = {Interleukin 6 as an Energy Allocator in Muscle Tissue},
  author = {Kistner, Timothy M. and Pedersen, Bente K. and Lieberman, Daniel E.},
  year = {2022},
  month = feb,
  journal = {Nature Metabolism},
  volume = {4},
  number = {2},
  pages = {170--179},
  issn = {2522-5812},
  doi = {10.1038/s42255-022-00538-4},
  urldate = {2024-04-29},
  langid = {english},
  file = {/Users/wudw/Zotero/storage/PDYRX2ZE/Kistner et al. - 2022 - Interleukin 6 as an energy allocator in muscle tis.pdf}
}

@article{kotasHomeostasisInflammationDisease2015,
  title = {Homeostasis, {{Inflammation}}, and {{Disease Susceptibility}}},
  author = {Kotas, Maya E. and Medzhitov, Ruslan},
  year = {2015},
  month = feb,
  journal = {Cell},
  volume = {160},
  number = {5},
  pages = {816--827},
  issn = {0092-8674},
  doi = {10.1016/j.cell.2015.02.010},
  urldate = {2024-05-14},
  abstract = {While modernization has dramatically increased lifespan, it has also witnessed the increasing prevalence of diseases such as obesity, hypertension, and type 2 diabetes. Such chronic, acquired diseases result when normal physiologic control goes awry and may thus be viewed as failures of homeostasis. However, while nearly every process in human physiology relies on homeostatic mechanisms for stability, only some have demonstrated vulnerability to dysregulation. Additionally, chronic inflammation is a common accomplice of the diseases of homeostasis, yet the basis for this connection is not fully understood. Here we review the design of homeostatic systems and discuss universal features of control circuits that operate at the cellular, tissue, and organismal levels. We suggest a framework for classification of homeostatic signals that is based on different classes of homeostatic variables they report on. Finally, we discuss how adaptability of homeostatic systems with adjustable set points creates vulnerability to dysregulation and disease. This framework highlights the fundamental parallels between homeostatic and inflammatory control mechanisms and provides a new perspective on the physiological origin of inflammation.},
  file = {/Users/wudw/Zotero/storage/U4Y4WCSL/Kotas and Medzhitov - 2015 - Homeostasis, Inflammation, and Disease Susceptibility.pdf}
}

@article{liuMetabolicReprogrammingMacrophage2021,
  title = {Metabolic Reprogramming in Macrophage Responses},
  author = {Liu, Yang and Xu, Ruyi and Gu, Huiyao and Zhang, Enfan and Qu, Jianwei and Cao, Wen and Huang, Xi and Yan, Haimeng and He, Jingsong and Cai, Zhen},
  year = {2021},
  month = dec,
  journal = {Biomarker Research},
  volume = {9},
  number = {1},
  pages = {1},
  issn = {2050-7771},
  doi = {10.1186/s40364-020-00251-y},
  urldate = {2024-04-30},
  abstract = {Macrophages are critical mediators of tissue homeostasis, with the function of tissue development and repair, but also in defense against pathogens. Tumor-associated macrophages (TAMs) are considered as the main component in the tumor microenvironment and play an important role in tumor initiation, growth, invasion, and metastasis. Recently, metabolic studies have revealeded specific metabolic pathways in macrophages are tightly associated with their phenotype and function. Generally, pro-inflammatory macrophages (M1) rely mainly on glycolysis and exhibit impairment of the tricarboxylic acid (TCA) cycle and mitochondrial oxidative phosphorylation (OXPHOS), whereas anti-inflammatory macrophages (M2) are more dependent on mitochondrial OXPHOS. However, accumulating evidence suggests that macrophage metabolism is not as simple as previously thought. This review discusses recent advances in immunometabolism and describes how metabolism determines macrophage phenotype and function. In addition, we describe the metabolic characteristics of TAMs as well as their therapeutic implications. Finally, we discuss recent obstacles facing this area as well as promising directions for future study.},
  langid = {english},
  file = {/Users/wudw/Zotero/storage/KE752B35/Liu et al. - 2021 - Metabolic reprogramming in macrophage responses.pdf}
}

@article{marthMammalianGlycosylationImmunity2008,
  title = {Mammalian Glycosylation in Immunity},
  author = {Marth, Jamey D. and Grewal, Prabhjit K.},
  year = {2008},
  month = nov,
  journal = {Nature Reviews Immunology},
  volume = {8},
  number = {11},
  pages = {874--887},
  issn = {1474-1733, 1474-1741},
  doi = {10.1038/nri2417},
  urldate = {2024-04-28},
  abstract = {Glycosylation produces a diverse and abundant repertoire of glycans, which are collectively known as the glycome. Glycans are one of the four fundamental macromolecular components of all cells, and are highly regulated in the immune system. Their diversity reflects their multiple biological functions that encompass ligands for proteinaceous receptors known as lectins. Since the discovery that selectins and their glycan ligands are important for the regulation of leukocyte trafficking, it has been shown that additional features of the vertebrate immune system are also controlled by endogenous cellular glycosylation. This Review focuses on the emerging immunological roles of the mammalian glycome.},
  langid = {english},
  file = {/Users/wudw/Zotero/storage/KAVVTFQ9/Marth and Grewal - 2008 - Mammalian glycosylation in immunity.pdf}
}

@article{medzhitovExploringNewPerspectives2024,
  title = {Exploring New Perspectives in Immunology},
  author = {Medzhitov, Ruslan and Iwasaki, Akiko},
  year = {2024},
  month = apr,
  journal = {Cell},
  volume = {187},
  number = {9},
  pages = {2079--2094},
  issn = {00928674},
  doi = {10.1016/j.cell.2024.03.038},
  urldate = {2024-04-28},
  abstract = {Several conceptual pillars form the foundation of modern immunology, including the clonal selection theory, antigen receptor diversity, immune memory, and innate control of adaptive immunity. However, some immunological phenomena cannot be explained by the current framework. Thus, we still do not know how to design vaccines that would provide long-lasting protective immunity against certain pathogens, why autoimmune responses target some antigens and not others, or why the immune response to infection sometimes does more harm than good. Understanding some of these mysteries may require that we question existing assumptions to develop and test alternative explanations. Immunology is increasingly at a point when, once again, exploring new perspectives becomes a necessity.},
  langid = {english},
  file = {/Users/wudw/Zotero/storage/8LC75NCR/Medzhitov and Iwasaki - 2024 - Exploring new perspectives in immunology.pdf}
}

@article{mullerIncreasedRiskCommon2005,
  title = {Increased {{Risk}} of {{Common Infections}} in {{Patients}} with {{Type}} 1 and {{Type}} 2 {{Diabetes Mellitus}}},
  author = {Muller, L. M. A. J. and Gorter, K. J. and Hak, E. and Goudzwaard, W. L. and Schellevis, F. G. and Hoepelman, A. I. M. and Rutten, G. E. H. M.},
  year = {2005},
  month = aug,
  journal = {Clinical Infectious Diseases},
  volume = {41},
  number = {3},
  pages = {281--288},
  issn = {1058-4838},
  doi = {10.1086/431587},
  urldate = {2024-05-14},
  abstract = {Background. Clinical data on the association of diabetes mellitus with common infections are virtually lacking, not conclusive, and often biased. We intended to determine the relative risks of common infections in patients with type 1 and type 2 diabetes mellitus (DM1 and DM2, respectively).Methods. In a 12-month prospective cohort study conducted as part of the Second Dutch National Survey of General Practice, we compared 705 adult patients who had DM1 and 6712 adult patients who had DM2 with 18,911 control patients who had hypertension without diabetes. Outcome measures were medically attended episodes of infection of the respiratory tract, urinary tract, and skin and mucous membranes. We applied multivariable and polytomous logistic regression analysis to determine independent risks of infections and their recurrences in patients with diabetes, compared with control patients.Results. Upper respiratory infections were equally common among patients with diabetes and control patients. Patients with diabetes had a greater risk of lower respiratory tract infection (for patients with DM1: adjusted odds ratio [AOR], 1.42 [95\% confidence interval \{CI\}, 0.96--2.08]; for patients with DM2: AOR, 1.32 [95\% CI, 1.13--1.53]), urinary tract infection (for patients with DM1: AOR, 1.96 [95\% CI, 1.49--2.58]; for patients with DM2: AOR, 1.24 [95\% CI, 1.10--1.39]), bacterial skin and mucous membrane infection (for patients with DM1: AOR, 1.59 [95\% CI, 1.12--2.24]; for patients with DM2: AOR, 1.33 [95\% CI, 1.15--1.54]), and mycotic skin and mucous membrane infection (for patients with DM1: AOR, 1.34 [95\% CI, 0.97--1.84]; for patients with DM2: AOR, 1.44 [95\% CI, 1.27--1.63]). Risks increased with recurrences of common infections.Conclusions. Patients with DM1 and DM2 are at increased risk for lower respiratory tract infection, urinary tract infection, and skin and mucous membrane infection. Studies are warranted into management of such infections in patients with diabetes.},
  file = {/Users/wudw/Zotero/storage/3RV7X89A/Muller et al. - 2005 - Increased Risk of Common Infections in Patients with Type 1 and Type 2 Diabetes Mellitus.pdf}
}

@article{normanExerciseDrivenInsulinIndependentGlucose2022,
  title = {An {{Exercise-Driven}}, {{Insulin-Independent Glucose Uptake Pathway}} in {{Contracting Skeletal Muscle}}},
  author = {Norman, Natalie J. and Ghali, Joyce and Radzyukevich, Tatiana and Landero, Julio and Heiny, Judith},
  year = {2022},
  month = may,
  journal = {The FASEB Journal},
  volume = {36},
  number = {S1},
  publisher = {John Wiley \& Sons, Ltd},
  issn = {0892-6638},
  doi = {10.1096/fasebj.2022.36.S1.R5513},
  urldate = {2024-05-15},
  abstract = {Glucose uptake by skeletal muscles, which import and store up to 80\% of circulating glucose, plays a major role in glucose homeostasis. Prior research has focused largely on the insulin regulated GLUT4 transporter, which mediates glucose uptake in quiescent (non-contracting) muscles using a canonical insulin-dependent translocation mechanism. An ongoing paradox in the field is that actively contracting muscles take up glucose at 50-100x greater rates than quiescent muscles, despite declining insulin levels. For this reason, exercise is a potent treatment for disorders of insulin insufficiency and insulin resistance. However, despite more than 30 years of study, the mechanism by which contracting muscles take up glucose without a requirement for insulin remains incompletely understood. It is proposed that GLUT4-translocation occurs using signaling pathways that bypass the insulin receptor. However, no GLUT4 models have accounted for all the glucose taken up by contracting muscles or the great discrepancy between measured GLUT4 translocation (2-fold increase in membrane density) and glucose uptake rate (50-100-fold increase), suggesting the existence of additional mechanisms. The goals of this study were to:i) develop a technology based on Inductively Coupled Plasma-Mass Spectroscopy (ICP-MS) that allows simultaneous detection of multiple transported species, including 13C-labeled hexoses; and ii) test the hypothesis that contraction-stimulated glucose uptake may be linked to Na,K-ATPase (NKA) transport, which is also dramatically stimulated during muscle contraction. We measured uptake of Rb (a congener for K+), and 13C-[6C]-D-glucose or 13C-[6C]-2-deoxy glucose in isolated mouse EDL muscles stimulated to contract ex vivo. Muscles were obtained from WT mice. Glucose uptake was measured for 5 min at 32 C in a physiological solution containing 200 mM tracer RbCl and 11mM 13C glucose. Following uptake, the Rb and 13C content of the muscle were measured by ICP-MS. We achieved a Limit of Detection of 54uM for 13C glucose in mouse muscle. This detection power for 13C by ICP-MS is entirely new and was achieved by combining technical approaches: i) introduction of 13C-based hexose substrates; ii) modifications to sample preparation that reduce background carbon; iii) ratiometric monitoring of the 13C/12C signal; and iv) 13C-optimized instrument conditions. Contracting skeletal muscle took up 13C-[6C]-labeled-D-glucose at a rate of 10.8 mM/g-min, and Rb at a rate of 1.2 mM/g-min. The ability to detect glucose and other carbon-based organic compounds by ICP-MS is expected to advance studies of coupled transport and other biological processes that require multi-species detection.}
}

@article{plitzkoMeasurementOxygenConsumption2018,
  title = {Measurement of {{Oxygen Consumption Rate}} ({{OCR}}) and {{Extracellular Acidification Rate}} ({{ECAR}}) in {{Culture Cells}} for {{Assessment}} of the {{Energy Metabolism}}},
  author = {Plitzko, Birte and Loesgen, Sandra},
  year = {2018},
  journal = {BIO-PROTOCOL},
  volume = {8},
  number = {10},
  issn = {2331-8325},
  doi = {10.21769/BioProtoc.2850},
  urldate = {2024-04-30},
  langid = {english},
  file = {/Users/wudw/Zotero/storage/2VISHDCA/Plitzko and Loesgen - 2018 - Measurement of Oxygen Consumption Rate (OCR) and E.pdf}
}

@article{rehmanMechanismsInflammatoryResponses2016,
  title = {Mechanisms of Inflammatory Responses and Development of Insulin Resistance: How Are They Interlinked?},
  shorttitle = {Mechanisms of Inflammatory Responses and Development of Insulin Resistance},
  author = {Rehman, Kanwal and Akash, Muhammad Sajid Hamid},
  year = {2016},
  month = dec,
  journal = {Journal of Biomedical Science},
  volume = {23},
  number = {1},
  pages = {87},
  issn = {1423-0127},
  doi = {10.1186/s12929-016-0303-y},
  urldate = {2024-05-13},
  abstract = {Insulin resistance (IR) is one of the major hallmark for pathogenesis and etiology of type 2 diabetes mellitus (T2DM). IR is directly interlinked with various inflammatory responses which play crucial role in the development of IR. Inflammatory responses play a crucial role in the pathogenesis and development of IR which is one of the main causative factor for the etiology of T2DM.},
  keywords = {Diabetes mellitus,Insulin resistance,Insulin sensitivity,Pro-inflammatory mediators,Transcriptional pathways},
  file = {/Users/wudw/Zotero/storage/EGSAZNMH/Rehman and Akash - 2016 - Mechanisms of inflammatory responses and development of insulin resistance how are they interlinked.pdf}
}

@article{roseSkeletalMuscleGlucose2005,
  title = {Skeletal {{Muscle Glucose Uptake During Exercise}}: {{How}} Is It {{Regulated}}?},
  shorttitle = {Skeletal {{Muscle Glucose Uptake During Exercise}}},
  author = {Rose, Adam J. and Richter, Erik A.},
  year = {2005},
  month = aug,
  journal = {Physiology},
  volume = {20},
  number = {4},
  pages = {260--270},
  issn = {1548-9213, 1548-9221},
  doi = {10.1152/physiol.00012.2005},
  urldate = {2024-04-30},
  abstract = {The increase in skeletal muscle glucose uptake during exercise results from a coordinated increase in rates of glucose delivery (higher capillary perfusion), surface membrane glucose transport, and intracellular substrate flux through glycolysis. The mechanism behind the movement of GLUT4 to surface membranes and the subsequent increase in transport by muscle contractions is largely unresolved, but it is likely to occur through intracellular signaling involving Ca               2+               -calmodulin-dependent protein kinase, 5{$\prime$}-AMP-activated protein kinase, and possibly protein kinase C.},
  langid = {english},
  file = {/Users/wudw/Zotero/storage/UPF3ZY7D/Rose and Richter - 2005 - Skeletal Muscle Glucose Uptake During Exercise Ho.pdf}
}

@article{roseSkeletalMuscleGlucose2005a,
  title = {Skeletal {{Muscle Glucose Uptake During Exercise}}: {{How}} Is It {{Regulated}}?},
  shorttitle = {Skeletal {{Muscle Glucose Uptake During Exercise}}},
  author = {Rose, Adam J. and Richter, Erik A.},
  year = {2005},
  month = aug,
  journal = {Physiology},
  volume = {20},
  number = {4},
  pages = {260--270},
  publisher = {American Physiological Society},
  issn = {1548-9213},
  doi = {10.1152/physiol.00012.2005},
  urldate = {2024-05-15},
  abstract = {The increase in skeletal muscle glucose uptake during exercise results from a coordinated increase in rates of glucose delivery (higher capillary perfusion), surface membrane glucose transport, and intracellular substrate flux through glycolysis. The mechanism behind the movement of GLUT4 to surface membranes and the subsequent increase in transport by muscle contractions is largely unresolved, but it is likely to occur through intracellular signaling involving Ca2+-calmodulin-dependent protein kinase, 5{$\prime$}-AMP-activated protein kinase, and possibly protein kinase C.},
  file = {/Users/wudw/Zotero/storage/2FLP5S8Y/Rose and Richter - 2005 - Skeletal Muscle Glucose Uptake During Exercise How is it Regulated.pdf}
}

@article{shestovSimultaneousMeasurementGlucose2011,
  title = {Simultaneous Measurement of Glucose Transport and Utilization in the Human Brain},
  author = {Shestov, Alexander A. and Emir, Uzay E. and Kumar, Anjali and Henry, Pierre-Gilles and Seaquist, Elizabeth R. and {\"O}z, G{\"u}lin},
  year = {2011},
  month = nov,
  journal = {American Journal of Physiology-Endocrinology and Metabolism},
  volume = {301},
  number = {5},
  pages = {E1040-E1049},
  issn = {0193-1849, 1522-1555},
  doi = {10.1152/ajpendo.00110.2011},
  urldate = {2024-04-30},
  abstract = {Glucose is the primary fuel for brain function, and determining the kinetics of cerebral glucose transport and utilization is critical for quantifying cerebral energy metabolism. The kinetic parameters of cerebral glucose transport, K               M               t               and V               max               t               , in humans have so far been obtained by measuring steady-state brain glucose levels by proton (               1               H) NMR as a function of plasma glucose levels and fitting steady-state models to these data. Extraction of the kinetic parameters for cerebral glucose transport necessitated assuming a constant cerebral metabolic rate of glucose ( CMR               glc               ) obtained from other tracer studies, such as               13               C NMR. Here we present new methodology to simultaneously obtain kinetic parameters for glucose transport and utilization in the human brain by fitting both dynamic and steady-state               1               H NMR data with a reversible, non-steady-state Michaelis-Menten model. Dynamic data were obtained by measuring brain and plasma glucose time courses during glucose infusions to raise and maintain plasma concentration at {$\sim$}17 mmol/l for {$\sim$}2 h in five healthy volunteers. Steady-state brain vs. plasma glucose concentrations were taken from literature and the steady-state portions of data from the five volunteers. In addition to providing simultaneous measurements of glucose transport and utilization and obviating assumptions for constant CMR               glc               , this methodology does not necessitate infusions of expensive or radioactive tracers. Using this new methodology, we found that the maximum transport capacity for glucose through the blood-brain barrier was nearly twofold higher than maximum cerebral glucose utilization. The glucose transport and utilization parameters were consistent with previously published values for human brain.},
  langid = {english},
  file = {/Users/wudw/Zotero/storage/E3Y9SE9R/Shestov et al. - 2011 - Simultaneous measurement of glucose transport and .pdf}
}

@article{sinclairSingleCellGlucose2020,
  title = {Single {{Cell Glucose Uptake Assays}}: {{A Cautionary Tale}}},
  shorttitle = {Single {{Cell Glucose Uptake Assays}}},
  author = {Sinclair, Linda V. and Barthelemy, Celine and Cantrell, Doreen A.},
  year = {2020},
  month = oct,
  journal = {Immunometabolism},
  volume = {2},
  number = {4},
  issn = {2633-0407},
  doi = {10.20900/immunometab20200029},
  urldate = {2024-04-30},
  abstract = {Assays to monitor the metabolic state or nutrient uptake capacity of immune cells at a single cell level are increasingly in demand. One assay, used by many immunologists, employs 2-(N-(7Nitrobenz-2-oxa-1,3-diazol-4-yl)Amino)-2-Deoxyglucose (2-NBDG), a fluorescent analogue of 2deoxyglucose (2DG), as a substrate for glucose transporters. This molecule has been validated as a substrate for the glucose transporter Glut2 (Slc2a2) in mammalian cells but 2-NDBG selectivity for the glucose transporters expressed by T cells, Glut1 (Slc2a1) and Glut3 (Slc2a3), has never been explored. Nor has the possibility that 2-NBDG might bind to T cells that do not express glucose transporters been assessed. In this technical commentary we interrogate the specificity of 2-NBBG labelling as a readout for glucose transport in T lymphocytes. We compare flow cytometric 2-NBDG staining against well validated radiolabelled glucose transport assays in murine T cells. Our data show there can be a large discordance between glucose transport capacity and 2-NBDG labelling in T cells. We also find that 2-NBDG uptake into murine T cells is not inhibited by competitive substrates or facilitative glucose transporter inhibitors, nor can 2-NBDG competitively block glucose uptake in T cells. Collectively, these data argue that 2-NBDG uptake alone is not a reliable tool for the assessment of cellular glucose transport capacity.},
  copyright = {http://creativecommons.org/licenses/by-nc-nd/4.0},
  langid = {english},
  file = {/Users/wudw/Zotero/storage/HX3T6EP3/Sinclair et al. - 2020 - Single Cell Glucose Uptake Assays A Cautionary Ta.pdf}
}

@misc{sompayracHowImmuneSystem,
  title = {How the {{Immune System Works}}, 7th {{Edition}} {\textbar} {{Wiley}}},
  author = {Sompayrac, Lauren M},
  journal = {Wiley.com},
  urldate = {2024-04-30},
  abstract = {How the Immune System Works How the Immune System Works provides a concise and accessible overview of how the immune system protects us from disease. Written in a lively and engaging style, this unique book makes it easy to see the big picture of the immune system---without any confusing jargon or complex technical details. Now in its seventh edition, this popular book features an entirely new chapter that describes the role of the immune system in fighting COVID-19, as well as up-to-date information on vaccines, immunotherapies, immunological memory, cancer, and more. This new edition includes a wide range of effective learning features, such as enhanced artwork, ``heads up!'' boxes that outline each chapter, and an expanding summary figure at the end of each chapter that illustrates the interaction of different parts of the immune system. How the Immune System Works, Seventh Edition is a must-have for all medical students, bioscience students, veterinary students, nursing students, researchers looking for a quick refresher, and general readers with interest in the subject. Reviews of the previous edition: ``The voice of the author is one of a true teacher whose enthusiasm for the subject is contagious. There are far too many dry `academic', or `scientific' textbooks around and this book felt very fresh in comparison.'' ---Medical Student, University of Texas, South Western Medical Center at Dallas ``This is the book that every student (regardless of level) should read as he or she begins to study immunology.'' ---Daniel G. Tenen, M.D. Professor of Medicine, Harvard Medical School},
  howpublished = {https://www.wiley.com/en-us/How+the+Immune+System+Works\%2C+7th+Edition-p-9781119890683},
  langid = {american},
  file = {/Users/wudw/Zotero/storage/JTUB5GZ3/Sompayrac.pdf}
}

@article{straubBrainImmuneSystem2017,
  title = {The Brain and Immune System Prompt Energy Shortage in Chronic Inflammation and Ageing},
  author = {Straub, Rainer H.},
  year = {2017},
  month = dec,
  journal = {Nature Reviews Rheumatology},
  volume = {13},
  number = {12},
  pages = {743--751},
  issn = {1759-4790, 1759-4804},
  doi = {10.1038/nrrheum.2017.172},
  urldate = {2024-04-29},
  abstract = {Sequelae frequently seen in patients with chronic inflammatory diseases, such as fatigue, depressed mood, sleep alterations, loss of appetite, muscle wasting, cachectic obesity, bone loss and hypertension, can be the result of energy shortages caused by an overactive immune system. These sequelae can also be found in patients with chronic inflammatory diseases that are in remission and in ageing individuals, despite the immune system being less active in these situations. This Perspectives article proposes a new way of understanding situations of chronic inflammation (such as rheumatic diseases) and ageing based on the principles of evolutionary medicine, energy regulation and neuroendocrine--immune crosstalk. A conceptual framework is provided to enable physicians and scientists to better understand the signs and symptoms of chronic inflammatory diseases and long-term disease consequences resulting from physical and mental inactivity.},
  langid = {english},
  file = {/Users/wudw/Zotero/storage/EFECLUQD/Straub - 2017 - The brain and immune system prompt energy shortage.pdf}
}

@article{straubEnergyRegulationNeuroendocrine2010,
  title = {Energy Regulation and Neuroendocrine--Immune Control in Chronic Inflammatory Diseases},
  author = {Straub, R. H. and Cutolo, M. and Buttgereit, F. and Pongratz, G.},
  year = {2010},
  month = jun,
  journal = {Journal of Internal Medicine},
  volume = {267},
  number = {6},
  pages = {543--560},
  issn = {0954-6820, 1365-2796},
  doi = {10.1111/j.1365-2796.2010.02218.x},
  urldate = {2024-04-29},
  abstract = {Straub RH, Cutolo M, Buttgereit F, Pongratz G (University Hospital Regensburg, Regensburg, Germany; University of Genova, Genova, Italy; and Charite{\textasciiacute} University Medicine Berlin, Berlin, Germany). Energy regulation and neuroendocrine--immune control in chronic inflammatory diseases (Review). J Intern Med 2010; 267: 543--560.},
  copyright = {http://onlinelibrary.wiley.com/termsAndConditions\#vor},
  langid = {english},
  file = {/Users/wudw/Zotero/storage/X98GXWZH/Straub et al. - 2010 - Energy regulation and neuroendocrineâ€“immune contro.pdf}
}

@article{wangConcentrationGradientGeneration2017,
  title = {Concentration Gradient Generation Methods Based on Microfluidic Systems},
  author = {Wang, Xiang and Liu, Zhaomiao and Pang, Yan},
  year = {2017},
  journal = {RSC Advances},
  volume = {7},
  number = {48},
  pages = {29966--29984},
  publisher = {Royal Society of Chemistry},
  doi = {10.1039/C7RA04494A},
  urldate = {2024-05-15},
  langid = {english},
  file = {/Users/wudw/Zotero/storage/49D3K2RP/Wang et al. - 2017 - Concentration gradient generation methods based on microfluidic systems.pdf}
}

@misc{wangDesignedMosaicNanoparticles2024,
  title = {Designed Mosaic Nanoparticles Enhance Cross-Reactive Immune Responses in Mice},
  author = {Wang, Eric and Cohen, Alexander A. and Caldera, Luis F. and Keeffe, Jennifer R. and Rorick, Annie V. and Aida, Yusuf M. and Gnanapragasam, Priyanthi N.P. and Bjorkman, Pamela J. and Chakraborty, Arup K.},
  year = {2024},
  month = feb,
  doi = {10.1101/2024.02.28.582544},
  urldate = {2024-04-28},
  abstract = {Summary                        Using computational methods, we designed 60-mer nanoparticles displaying SARS-like betacoronavirus (sarbecovirus) receptor-binding domains (RBDs) by (             i             ) creating RBD sequences with 6 mutations in the SARS-COV-2 WA1 RBD that were predicted to retain proper folding and abrogate antibody responses to variable epitopes (mosaic-2             COM             s; mosaic-5             COM             ), and (             ii             ) selecting 7 natural sarbecovirus RBDs (mosaic-7             COM             ). These antigens were compared with mosaic-8b, which elicits cross-reactive antibodies and protects from sarbecovirus challenges in animals. Immunizations in na{\"i}ve and COVID-19 pre-vaccinated mice revealed that mosaic-7             COM             elicited higher binding and neutralization titers than mosaic-8b and related antigens. Deep mutational scanning showed that mosaic-7             COM             targeted conserved RBD epitopes. Mosaic-2             COM             s and mosaic-5             COM             elicited higher titers than homotypic SARS-CoV-2 Beta RBD-nanoparticles and increased potencies against some SARS-CoV-2 variants than mosaic-7             COM             . However, mosaic-7             COM             elicited more potent responses against zoonotic sarbecoviruses and highly mutated Omicrons. These results support using mosaic-7             COM             to protect against highly mutated SARS-CoV-2 variants and zoonotic sarbecoviruses with spillover potential.},
  langid = {english},
  file = {/Users/wudw/Zotero/storage/USIXLKD3/Wang et al. - 2024 - Designed mosaic nanoparticles enhance cross-reacti.pdf}
}

@article{watersInitialCellActivation2018,
  title = {Initial {{B Cell Activation Induces Metabolic Reprogramming}} and {{Mitochondrial Remodeling}}},
  author = {Waters, Lynnea R. and Ahsan, Fasih M. and Wolf, Dane M. and Shirihai, Orian and Teitell, Michael A.},
  year = {2018},
  month = jul,
  journal = {iScience},
  volume = {5},
  pages = {99--109},
  issn = {25890042},
  doi = {10.1016/j.isci.2018.07.005},
  urldate = {2024-04-30},
  abstract = {B lymphocytes provide adaptive immunity by generating antigen-specific antibodies and supporting the activation of T cells. Little is known about how global metabolism supports naive B cell activation to enable an effective immune response. By coupling RNA sequencing (RNA-seq) data with glucose isotopomer tracing, we show that stimulated B cells increase programs for oxidative phosphorylation (OXPHOS), the tricarboxylic acid (TCA) cycle, and nucleotide biosynthesis, but not glycolysis. Isotopomer tracing uncovered increases in TCA cycle intermediates with almost no contribution from glucose. Instead, glucose mainly supported the biosynthesis of ribonucleotides. Glucose restriction did not affect B cell functions, yet the inhibition of OXPHOS or glutamine restriction markedly impaired B cell growth and differentiation. Increased OXPHOS prompted studies of mitochondrial dynamics, which revealed extensive mitochondria remodeling during activation. Our results show how B cell metabolism adapts with stimulation and reveals unexpected details for carbon utilization and mitochondrial dynamics at the start of a humoral immune response.},
  langid = {english},
  file = {/Users/wudw/Zotero/storage/A96DQKHM/Waters et al. - 2018 - Initial B Cell Activation Induces Metabolic Reprog.pdf}
}

@article{wellenInflammationStressDiabetes2005,
  title = {Inflammation, Stress, and Diabetes},
  author = {Wellen, Kathryn E. and Hotamisligil, G{\"o}khan S.},
  year = {2005},
  month = may,
  journal = {Journal of Clinical Investigation},
  volume = {115},
  number = {5},
  pages = {1111--1119},
  issn = {0021-9738},
  doi = {10.1172/JCI200525102},
  urldate = {2024-05-13},
  abstract = {Over the last decade, an abundance of evidence has emerged demonstrating a close link between metabolism and immunity. It is now clear that obesity is associated with a state of chronic low-level inflammation. In this article, we discuss the molecular and cellular underpinnings of obesity-induced inflammation and the signaling pathways at the intersection of metabolism and inflammation that contribute to diabetes. We also consider mechanisms through which the inflammatory response may be initiated and discuss the reasons for the inflammatory response in obesity. We put forth for consideration some hypotheses regarding important unanswered questions in the field and suggest a model for the integration of inflammatory and metabolic pathways in metabolic disease.},
  pmcid = {PMC1087185},
  pmid = {15864338},
  file = {/Users/wudw/Zotero/storage/B2CF8KTM/Wellen and Hotamisligil - 2005 - Inflammation, stress, and diabetes.pdf}
}
